For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.63 down -5.89% from its previous closing price of $0.67. In other words, the price has decreased by -$5.89 from its previous closing price. On the day, 0.67 million shares were traded. KPTI stock price reached its highest trading level at $0.6998 during the session, while it also had its lowest trading level at $0.6332.
Ratios:
For a deeper understanding of Karyopharm Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 3.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when Paulson Richard A. sold 4,055 shares for $0.78 per share. The transaction valued at 3,175 led to the insider holds 1,124,257 shares of the business.
Paulson Richard A. sold 3,620 shares of KPTI for $2,932 on Dec 04 ’24. The President and CEO now owns 1,128,312 shares after completing the transaction at $0.81 per share. On Nov 05 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,675 shares for $0.91 each. As a result, the insider received 3,346 and left with 1,131,932 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 79904136 and an Enterprise Value of 213582144. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.54. Its current Enterprise Value per Revenue stands at 1.439 whereas that against EBITDA is -1.7.
Stock Price History:
The Beta on a monthly basis for KPTI is 0.06, which has changed by -0.10860926 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -18.37%, while the 200-Day Moving Average is calculated to be -30.25%.
Shares Statistics:
For the past three months, KPTI has traded an average of 952.90K shares per day and 1155400 over the past ten days. A total of 125.30M shares are outstanding, with a floating share count of 115.36M. Insiders hold about 8.58% of the company’s shares, while institutions hold 47.15% stake in the company. Shares short for KPTI as of 1735603200 were 19461323 with a Short Ratio of 20.42, compared to 1732838400 on 18922751. Therefore, it implies a Short% of Shares Outstanding of 19461323 and a Short% of Float of 15.540000000000001.
